NEW YORK (GenomeWeb) – MDxHealth announced today that it has signed a deal to distribute its SelectMDx for Prostate Cancer test in various countries in Central and South America.

Under the terms of the agreement, Uruguay-based biotechnology company SouthGenetics will have the rights to distribute SelectMDx in Argentina, Bolivia, Chile, Columbia, Ecuador, Mexico, Peru, the Dominican Republic, Panama, Paraguay, Uruguay, and Venezuela.

Further terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.